Imbruvica

Made by

• Janssen Pharmaceutical

Active Ingredient

Ibrutinib

Prospectus

Approval date

2016/3/28

Treats

• Mantle cell lymphoma
• Chronic lymphocytic leukemia

Dosages

• IMBRUVICA Capsules - 10134.8円／カプセル